Download PDF
CC BY-NC-ND 4.0 · Eur J Dent 2021; 15(04): 675-681
DOI: 10.1055/s-0041-1728230
Original Article

A Meta-Analysis in Assessing Oxidative Stress Using Malondialdehyde in Oral Submucous Fibrosis

Khadijah Mohideen
1   Department of Oral Pathology and Microbiology, Dr. M.G.R. Educational and Research Institute, Thai Moogambigai Dental College and Hospital, Chennai, Tamil Nadu, India
,
Chandrasekaran Krithika
2   Department of Oral Medicine and Radiology, Dr. M.G.R. Educational and Research Institute, Thai Moogambigai Dental College and Hospital, Chennai, Tamil Nadu, India
,
Nadeem Jeddy
1   Department of Oral Pathology and Microbiology, Dr. M.G.R. Educational and Research Institute, Thai Moogambigai Dental College and Hospital, Chennai, Tamil Nadu, India
,
Sameena Parveen
3   Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan, Saudi Arabia
,
Thangavelu Radhika
1   Department of Oral Pathology and Microbiology, Dr. M.G.R. Educational and Research Institute, Thai Moogambigai Dental College and Hospital, Chennai, Tamil Nadu, India
,
S. Leena Sankari
4   Department of Oral Pathology and Microbiology, Bharath Institute of Higher Education and Research, Sree Balaji Dental College and Hospital, Chennai, Tamil Nadu, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objective This study aimed to evaluate the oxidative stress (OS) marker Malondialdehyde (MDA) in oral submucous fibrosis with available literature.

Materials and Methods We conducted a literature search electronically in PubMed (MeSH), Science Direct, Scopus, and Google Scholar using specific keywords.

Results A systematic search in PubMed, Science Direct, and Google Scholar identified 334 articles. Of these, four were duplicate reports, and three were animal studies. After reading the abstracts of the collected articles, 288 articles were excluded for the following reasons: low quality, not relevant to the research question, or did not meet the inclusion criteria. The remaining 46 articles were chosen for full-text assessment. Finally, the present qualitative synthesis included 23 articles for evaluation. The selected studies in MDA analysis in a random-effects model showed higher heterogeneity (Q = 477.636, p < 0.001, I2 = 95.394%). The standard difference in mean MDA concentration between oral submucous fibrosis (OSMF) and healthy subjects was estimated as 2.73 nmol/mL (95% confidence interval: 2.08–3.38).

Conclusion The selected studies showed significantly higher MDA levels in various biological samples of patients with OSMF. Therefore, further studies are needed to estimate oxidative stress levels by using different biomarkers in OSMF to direct future therapy.

Keywords

oral submucous fibrosis - potentially malignant disorders - precancer - oxidative stress


Publication History

Article published online:
24 August 2021

© 2021. European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Shetty SR, Babu SG, Kumari S, Rao V, Vijay R, Karikal A. Malondialdehyde levels in oral sub mucous fibrosis: a clinicopathological and biochemical study. N Am J Med Sci 2012; 4 (03) 125-128
    CrossrefPubMedGoogle Scholar
  • 2 Kanodia S, Giri VP, Giri OP, Devi MP, Garima Y. Assessment of anxiety, depression, and serum cortisol level in oral submucous fibrosis patients: a controlled clinical trial. Eur J Dent 2017; 11 (03) 293-298
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Rajakumar P, Saravanan R, Prabhakar R, Kumar RV, Abinesh S, Vivakanandhan U. Role of anti-oxidants in oral submucous fibrosis. J Int Oral Health 2016; 8: 412-414
    Google Scholar
  • 4 Poorani R, Vezhavendhan N, Ramesh R. Vidhya Lakshmi S, Sivaramakrishnan M, Suganya R. Malondialdehyde level in oral submucous fibrosis. J Sci Dent 2014; 4 (02) 8-13
    Google Scholar
  • 5 D’souza D, Subhas BG, Shetty SR, Balan P. Estimation of serum malondialdehyde in potentially malignant disorders and post-antioxidant treated patients: a biochemical study. Contemp Clin Dent 2012; 3 (04) 448-451
    CrossrefPubMedGoogle Scholar
  • 6 Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006; 42 (06) 561-568
    CrossrefPubMedGoogle Scholar
  • 7 Vincent RR, Appukuttan D, Victor DJ, Balasundaram A. Oxidative stress in chronic periodontitis patients with type II diabetes mellitus. Eur J Dent 2018; 12 (02) 225-231
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent 2009; 3 (02) 100-106
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Irshad M, Chaudhuri PS. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol 2002; 40 (11) 1233-1239
    PubMedGoogle Scholar
  • 10 Yegambaram M, Manivannan B, Beach TG, Halden RU. Role of environmental contaminants in the etiology of Alzheimer’s disease: a review. Curr Alzheimer Res 2015; 12 (02) 116-146
    CrossrefPubMedGoogle Scholar
  • 11 Anderson RA, Evans ML, Ellis GR. et al The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001; 154 (02) 475-483
    CrossrefPubMedGoogle Scholar
  • 12 Sadaksharam J. Significance of serum nitric oxide and superoxide dismutase in oral submucous fibrosis and squamous cell carcinoma: a comparative study. Contemp Clin Dent 2018; 9 (02) 283-288
    CrossrefPubMedGoogle Scholar
  • 13 Matsui A, Ikeda T, Enomoto K. et al Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 2000; 151 (01) 87-95
    CrossrefPubMedGoogle Scholar
  • 14 Tseng SK, Chang MC, Su CY. et al Arecoline induced cell cycle arrest, apoptosis, and cytotoxicity to human endothelial cells. Clin Oral Investig 2012; 16 (04) 1267-1273
    CrossrefPubMedGoogle Scholar
  • 15 Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39 (01) 44-84
    CrossrefPubMedGoogle Scholar
  • 16 Lü JM, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 2010; 14 (04) 840-860
    CrossrefPubMedGoogle Scholar
  • 17 Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012; 5 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 18 Aradhya CBV, Britto F, Kaikure SLHG, Paul T, Sishan U, Abdulrashid B. Shubhalakshmi. “Oxidants to assess the oxidative stress in oral submucous fibrosis. Int J CurrAdv Res 2018; 7 (08) 14973-14975
    Google Scholar
  • 19 Gokul S, Patil VS, Jailkhani R, Hallikeri K, Kattappagari KK. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010; 16 (01) 29-33
    CrossrefPubMedGoogle Scholar
  • 20 Gupta S, Reddy MV, Harinath BC. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 2004; 19 (01) 138-141
    CrossrefPubMedGoogle Scholar
  • 21 Agrawal S, Ambad RS. Evaluation of anti-oxidant status in oral submucous fibrosis: a hospital based study. Int J Innovat Res Med Sci 2017; 2: 7
    Google Scholar
  • 22 Shakunthala GK, Annigeri RG, Arunkumar S. Role of oxidative stress in the pathogenesis of oral submucous fibrosis: A preliminary prospective study. Contemp Clin Dent 2015; 6 (Suppl. 01) S172-S174
    CrossrefPubMedGoogle Scholar
  • 23 Subramanyam D, Gurunathan D, Gaayathri R. Vishnu Priya V. Comparative evaluation of salivary malondialdehyde levels as a marker of lipid peroxidation in early childhood caries. Eur J Dent 2018; 12 (01) 67-70
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012; 2012: 137289
    PubMedGoogle Scholar
  • 25 Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 1999; 274 (28) 19661-19669
    CrossrefPubMedGoogle Scholar
  • 26 Metkari S, Tupkari J, Barpande S. An estimation of serum malondialdehyde, superoxide dismutase and vitamin A in oral submucous fibrosis and its clinicopathologic correlation. J Oral Maxillofac Pathol 2007; 11 (01) 23-27
    CrossrefGoogle Scholar
  • 27 Uikey AK, Hazarey VK, Vaidhya SM. Estimation of serum anti-oxidant enzymes superoxide dismutase and glutathione peroxidase in oral submucous fibrosis: a biochemical study. J Maxillofac Pathol. 2003; 7: 44-52
    CrossrefGoogle Scholar
  • 28 Patel T, Kulkarni V. A study on anti-oxidant levels in non smoke tobacco consuming oral sub mucous fibrosis (OSMF). Int J Med Res Heal Sci 2013; 2: 229
    Google Scholar
  • 29 Avinash Tejasvi ML, Bangi BB, Geetha P. et al Estimation of serum superoxide dismutase and serum malondialdehyde in oral submucous fibrosis: a clinical and biochemical study. J Cancer Res Ther 2014; 10 (03) 722-725
    PubMedGoogle Scholar
  • 30 Purohit CS. Total anti-oxidant activity - a biomarker in oral precancer patients. Int J Curr Res Rev 2014; 6: 21-24
    Google Scholar
  • 31 Rai S, Sharma A, Ranjan V, Misra D, Panjwani S. Estimation of serum anti-oxidant enzymes in histopathological grades of oral leukoplakia, oral submucous fibrosis, and oral cancer: a clinicopathologic study. J Indian Acad Oral Med Radiol 2015; 27: 349
    CrossrefGoogle Scholar
  • 32 Paulose S, Rangdhol V, Ramesh R, Jeelani SA, Brooklyin S. Estimation of serum malondialdehyde and assessment of DNA damage using comet assay in patients with oral submucous fibrosis. J Investig Clin Dent 2016; 7 (03) 286-293
    CrossrefPubMedGoogle Scholar
  • 33 Nyamati SB, Annapoorna HB, Tripathi J, Sinha N, Roy S, Agrawal R. Evaluation of serum anti-oxidant enzymes in oral submucous fibrosis and oral squamous cell carcinoma: a clinical and biochemical study. J Adv Med Dent Sci Res 2016; 4: 83-87
    Google Scholar
  • 34 Bale R, Kattappagari KK, Vidya D, Vuddandi S, Gummalla C, Baddam VRR. Oral submucous fibrosis: a quantitative assessment of serum malondialdehyde, superoxide dismutase and correlation with clinical staging. J Oral Maxillofac Pathol 2017; 21 (01) 41-45
    CrossrefPubMedGoogle Scholar
  • 35 Basu S, Guhan VN. Enzymatic and non-enzymatic anti-oxidants changes in pre-cancerous and cancerous lesions of oral cavity. Med Pulse Int J Biochem 2018; 5: 54-58
    Google Scholar
  • 36 Divyambika CV, Sathasivasubramanian S, Vani G, Vanishree AJ, Malathi N. Correlation of clinical and histopathological grades in oral submucous fibrosis patients with oxidative stress markers in saliva. Indian J Clin Biochem 2018; 33 (03) 348-355
    CrossrefPubMedGoogle Scholar
  • 37 Param K, Kanchan M, Manish P, Satish K. Assessment of serum paraoxonase-1 enzyme activity, malondialdehyde and vitamin-C in oral premalignancies. Int J Clin Biomed Res 2018; 4: 21-26
    CrossrefGoogle Scholar
  • 38 Arya H, Ganvir SM, Begde DN, Passi AD. Comparative evaluation of serum malondialdehyde (MDA) level in oral submucous fibrosis and oral squamous cell carcinoma. J Clin Diagn Res 2019; 13 (06) ZC27-ZC31
    Google Scholar
  • 39 Bathi RJ, Rao R, Mutalik S. GST null genotype and antioxidants: risk indicators for oral pre-cancer and cancer. Indian J Dent Res 2009; 20 (03) 298-303
    CrossrefPubMedGoogle Scholar
  • 40 Oswal RG, Rao KN, Mall P, Grover I. Evaluation of serum antioxidant enzymes in oral submucous fibrosis and oral squamous cell carcinoma- a clinical and biochemical study. Eur J Mol Clin Med 2020; 7 (08) 3205-3209
    Google Scholar
  • 41 Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 2010; 52 (02) 251-256
    CrossrefPubMedGoogle Scholar
  • 42 Shetty SR, Babu S, Kumari S, Shetty P, Hegde S, Castelino R. Status of salivary lipid peroxidation in oral cancer and precancer. Indian J Med Paediatr Oncol 2014; 35 (02) 156-158
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Kaur J, Politis C, Jacobs R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig 2016; 20 (02) 315-319
    CrossrefPubMedGoogle Scholar
  • 44 Akhlaq H, Mehmood N, Azfar M. Increase level of salivary malondialdehyde is associated with decrease mouth opening in stage-I oral submucous fibrosis. Pak J Surg 2017; 33 (03) 195-200
    Google Scholar
  • 45 Banerjee S, Mukherjee S, Mitra S, Singhal P. Comparative evaluation of mitochondrial antioxidants in oral potentially malignant disorders. Kurume Med J 2020; 66 (01) 15-27
    CrossrefPubMedGoogle Scholar
  • 46 Shahi Y, Samadi FM, Mukherjee S. Plasma lipid peroxidation and anti-oxidant status in patients with oral pre-cancerous lesions and oral cancer. Oral Sci Int 2020; 0: 1-8
    Google Scholar
  • 47 Gupta RK, Patel AK, Shah N. et al Oxidative stress and antioxidants in disease and cancer: a review. Asian Pac J Cancer Prev 2014; 15 (11) 4405-4409
    CrossrefPubMedGoogle Scholar